CJEU Clarifies When Reverse Payment Patent Settlements Can Be…
In its ruling of 30 January 2020, the Court of Justice of the European Union (‘CJEU’) has clarified for the first time the criteria governing…
Tagged with Europe
Would the Last Pharmaceutical Investor in Europe Please Turn the…
EFPIA’s Nathalie Moll highlights how Europe can reverse its decline in the global medical research standings and once again make the continent a…
Brexit: Uncertainty Still Reigns for UK Life Sciences
Friday January 31 2020 was officially dubbed “Brexit Day” as the UK finally left the EU, following British Prime Minister Boris Johnson’s…
Mylan’s Arun Narayan Emphasizes Benefits of Value Added…
Arun Narayan of Medicines for Europe’s Value Added Medicines Group has been working to promote the benefits of value added medicines and how…
MSD SVP Deepak Khanna: Taking a Europe-Wide Approach in the Fight…
There are over 3.5 million diagnoses and 1.3 million deaths from cancer in the EU each year and cancer is set to become the region’s leading cause…
EMA Drugs Approved in 2019
An overview of the types of new medicines recommended for approval by the European Medicines Agency (EMA) in 2019. Made with Visme Infographic Maker…
Deepak Khanna – SVP & Regional President Oncology…
Speaking at the 2020 European Cancer Forum in Brussels, MSD’s Deepak Khanna outlines the progress that the company is making at the forefront of…
Arun Narayan – Chairman, Value Added Medicines Group,…
Arun Narayan is the Chairman of the Value Added Medicines Sector Group at Medicines for Europe, in addition to serving as Head of Global Portfolio…
Hungary Healthcare Snapshot 2020
Hungary lags behind much of Europe in terms of healthcare spending, according to the latest OECD report on the country. Made with…
Biosimilar Uptake in Europe: Big Challenges; Bigger Rewards
Isabell Remus, chair of the Biosimilar Medicines Group at Medicines for Europe outlines the issues that need to be addressed to keep driving…
Tending the Garden of RWD via Project EHDEN: 21st Century Tools…
Nigel Hughes of the European Health Data & Evidence Network (EHDEN) outlines EHDEN’s scope and purpose and highlights why greater…
A New Industrial Strategy for Europe: Win-Win for Both Economies…
The EFPIA’s Nathalie Moll outlines the case for a new EU-wide industrial strategy with biopharmaceuticals at its heart. The…
